ALFA FinderNSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹433.55
- Market cap
- ₹16,588 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 350.2×Sector 43.0×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Cohance Lifesciences Management Change
Cohance Lifesciences appointed Kuber Jagdale as Executive Director for 60 months, effective 7 November 2026. He brings over three decades of pharmaceutical manufacturing and operations experience.
Cohance Lifesciences Earnings Call Transcript: Key Takeaways
Q2 revenue rose about 13% QoQ to ₹477 Cr and adjusted EBITDA reached about ₹46 Cr (~10% margin), but both remain below last year. H2 YoY growth is promised without figures, and FY27 specialty chemicals guidance was cut to decline.
Cohance Lifesciences Results Update
Cohance Lifesciences issued a press release on its unaudited Q2 and H1 FY27 results. It reported lower year-on-year revenue and an expected stronger second half.
Cohance Lifesciences Investor Presentation: Key Takeaways
Q2FY27 revenue INR 4,766 Mn, down 14.2% YoY but up 12.9% QoQ. Adjusted EBITDA margin 9.6%, adjusted PAT INR 74 Mn back positive. Strategy centres on One Cohance integration and H2 recovery.
Cohance Lifesciences Q2 FY27 Results: Net Profit ₹2.3 Cr, Down 96.5% YoY
Cohance Lifesciences Ltd reported revenue from operations of ₹476.6 Cr (-14.2% YoY) and net profit of ₹2.3 Cr (-96.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.3 Cr · -96.5% YoY
Other annual general meeting announcements
All →Generic Engineering Construction and Projects Annual General Meeting
Generic Engineering's 32nd AGM is scheduled for November 30, 2026 via VC/OAVM. Agenda includes FY26 financial statements, director reappointment and related-party transactions approval.
Kirloskar Industries Annual General Meeting
Kirloskar Industries forwarded its subsidiary KFIL's postal ballot scrutinizer report. Shareholders passed resolutions appointing Ajay Shriram Patil as a director and as Joint Managing Director.
Umiya Tubes Annual General Meeting
Umiya Tubes submitted voting results and the scrutinizer report for its postal ballot ending 7 November 2026. Resolution 1, alteration of the name clause, passed as a special resolution with 100% of votes cast in favour.
Prime Focus Annual General Meeting
Prime Focus Limited's EOGM held on 7 November 2026 passed all resolutions with requisite majority. Resolutions cover cessation of control over Brahma AI Holdings and related party transactions involving its subsidiaries.
Jagsonpal Services Annual General Meeting
Jagsonpal Services shareholders approved an asset-acquisition business transfer agreement with Elanistech via postal ballot. A name-change certificate was also noted.
Vineet Laboratories Annual General Meeting
Vineet Laboratories has circulated notice of its 10th AGM, scheduled for 30 November 2026 via video conferencing. The filing attaches the FY 2025-26 annual report.